On the occasion of the publication of its annual results, Medtronic announces an increased quarterly dividend of $0.70 per share, marking its 47th consecutive year of increases, a dividend to be paid from July 12.
The medical equipment supplier reported adjusted EPS (non-GAAP) down 7% to $1.46 for the last three months of its 2023-24 financial year, on virtually stable revenues (+0.5%) of $8.59 billion (+5.4% on an organic basis).
We finished the year on a strong note, with great vigour in our businesses and each of our four segments posting organic revenue growth in the mid-single digits or higher", emphasizes CEO Geoff Martha.
With full-year adjusted EPS of $5.20 and organic revenue growth of 5.2%, Medtronic is targeting full-year adjusted EPS of $5.40 to $5.50 and organic revenue growth of 4 to 5% respectively.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows:
- general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;
- cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;
- vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;
- spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;
- neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%);
- diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps;
- neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc.
Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
MEDTRONIC PLC 
